SEC Form 4 · accession 0001209191-17-041093
Flexion Therapeutics Inc · FLXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Stejbach
Director
Period of report
Jun 16, 2017
Accepted (ET)
Jun 20, 2017 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419600
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 16, 2017 | P | 1,580 | $17.0178 | A | 1,580 | I | By The Mark P. Stejbach Revocable Trust UA 07-08-2016 |
Table II — derivative securities
No Table II lines on this filing.